newsfilter
← Latest News
GlobeNewswire·

Matinas BioPharma to Present at the JMP Securities Life Sciences Conference on May 15, 2023

BEDMINSTER, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE:MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform